E-LIB Suche - Ergebnisse für: Pius R

1

529 Gallstone Disease and the Risk of Cardiovascular Diseas..:

Fairfield, C ; Drake, T ; Pius, R...
British Journal of Surgery. 109 (2022) Supplement_6 - p. , 2022

Link: https://doi.org/10.1093/..

2

590 Influence of Hospital Characteristics on Patient Outcom..:

Knight, S ; Weiser, T ; Pius, R..
British Journal of Surgery. 108 (2021) Supplement_6 - p. , 2021

Link: https://doi.org/10.1093/..

3

A multicenter randomized controlled feasibility trial of le..:

Memmel, L. ; Godfrey, E. ; Nicosia, A....
Contraception. 80 (2009) 2 - p. 209 , 2009

Link: https://doi.org/10.1016/..

4

Knowledge, attitudes and practices regarding modern methods..:

Memmel, L. ; Buck, J. ; Pius, R....
Contraception. 78 (2008) 2 - p. 182 , 2008

Link: https://doi.org/10.1016/..

5

Cultural changes supporting use of modern methods of contra..:

Memmel, L. ; Buck, J. ; Pius, R....
Contraception. 78 (2008) 2 - p. 182-183 , 2008

Link: https://doi.org/10.1016/..

6

Development and external validation of the 'Global Surgical..:

NIHR Global Research Health Unit on Global Surgery and GlobalSurg Collaborative ; KA, McLean ; SR, Knight...
British Journal of Surgery. 111 (2024) 6 - p. , 2024

Link: https://doi.org/10.1093/..

7

Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID)..:

Elneima, O ; McAuley, HJC ; Leavy, OC...
International Journal of Epidemiology. , 2024

Link: https://qmro.qmul.ac.uk/..

8

Alternative pathway dysregulation in tissues drives sustain..:

Siggins, MK ; Davies, K ; Fellows, R...
https://discovery.ucl.ac.uk/id/eprint/10160844/1/Immunology%20-%202022%20-%20Siggins%20-%20Alternative%20pathway%20dysregulation%20in%20tissues%20drives%20sustained%20complement%20activation%20and.pdf. , 2023

Link: https://discovery.ucl.ac..

9

Para-infectious brain injury in COVID-19 persists at follow..:

Michael, B.D ; Dunai, C ; Needham, E.J...
https://eprints.whiterose.ac.uk/209289/1/s41467-023-42320-4.pdf. , 2023

Link: https://eprints.whiteros..

10

Quantifying neutralising antibody responses against SARS-Co..:

Roper, K.J ; Thomas, J ; Albalawi, W...
https://eprints.whiterose.ac.uk/205724/1/s41598-023-41928-2.pdf. , 2023

Link: https://eprints.whiteros..

11

Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID)..:

Elneima, O ; McAuley, H.J.C ; Leavy, O.C...
https://eprints.whiterose.ac.uk/207932/1/dyad165.pdf. , 2023

Link: https://eprints.whiteros..

12

Post-acute COVID-19 neuropsychiatric symptoms are not assoc..:

Taquet, M ; Skorniewska, Z ; Zetterberg, H...
https://eprints.whiterose.ac.uk/208018/1/fcad357.pdf. , 2023

Link: https://eprints.whiteros..

13

SARS-CoV-2-specific nasal IgA wanes 9 months after hospital..:

Liew, F ; Talwar, S ; Cross, A...
https://eprints.whiterose.ac.uk/195314/1/PIIS2352396422005849.pdf. , 2023

Link: https://eprints.whiteros..

14

Effects of hospital facilities on patient outcomes after ca..:

Knight S. R ; Shaw C. A ; Pius R...
info:eu-repo/semantics/altIdentifier/pmid/35623378. , 2022

Link: https://hdl.handle.net/1..

15

Effects of hospital facilities on patient outcomes after ca..:

Knight, SR ; Chu, K ; Lapitan, MC...
The Lancet Global Health. , 2022

Link: http://hdl.handle.net/10..